What You Should Know:
- Biotia, a company fighting infectious diseases powered by genomics and artificial intelligence (AI), has raised an oversubscribed $8 million Series A round led by OCA Ventures.
- OCA, a veteran early-stage venture firm operating from Chicago and Palo Alto was joined by other key investors including Continuum Health Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Digital-Dx Ventures, and others. Prior Seed round investors include Falcon II
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Challenges and Opportunities for At-Home COPD Management
There are an estimated 16 million Americans who suffer from Chronic Obstructive Pulmonary Disease (COPD). Patients with COPD are frequently prescribed respiratory medication and given at-home treatment strategies designed to improve general wellness and improve airflow. These strategies may include smoking cessation, air quality control, exercise, and stress management. Unfortunately, despite the use of medication and widespread adoption of lifestyle strategies, COPD continues to represent a
Read More
Cedars-Sinai Accelerator Adds 10 New Digital Health Startups
What You Should Know:
- Cedars-Sinai Accelerator, today announced its eighth accelerator class of ten new digital health startups.
- From digital health mental health services to wearable devices to manage chronic asthma, these innovative healthcare-focused startups are working to transform health and healthcare delivery as part of the Los Angeles-based accelerator program.
Cedars-Sinai Accelerator Overview
During the three-month term, company representatives collaborate with
Read More
Why There’s Renewed Interest In The Cloud for Healthcare
From the development of the EMR to the growth of telehealth, the digital environment for healthcare has evolved tremendously over the last few years. So, it’s no surprise that IT spending is set to increase by 12.3% for cloud computing, 9.7%, for digital transformation, and 9.7% for security software this year. Though healthcare organizations have historically been slower to adopt cloud, we’re now seeing renewed interest.
Has the pandemic caused a reaction among IT leaders to
Read More
Using AI to Match Patients with Clinical Trials for Proactive Treatment
We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. One of the more significant solutions that support the faster and more efficient development of new pharmaceutical products – such as the COVID-19 vaccine, which was developed faster than any other vaccine in history – is artificial intelligence (AI)-driven data analysis. Thanks to modern life science technology
Read More
EchoNous Alliance with Samsung for AI-Guided Ultrasound
What You Should Know:
- EchoNous, a company delivering AI-enabled handheld ultrasound capable of producing diagnostic-quality images, forms an alliance with Samsung that enables its Point-of-Care Ultrasound (POCUS) Kosmos platform run on Samsung’s Galaxy Tab Pro tablets (models 12.0 and higher).
- Made possible through the EchoNous/Samsung alliance, this new compatibility will lower the overall price point of the Kosmos platform, which already costs tens of thousands of dollars less than
Read More
Connected Devices Selection: Considerations for A Digital-First Approach to Data Collection
In recent years, digital health technologies (DHTs) have significantly changed the way we collect data within clinical trials. This is partially due to the overarching industry shift toward patient-centricity, but in some cases, it is also due to the commercial availability of powerful technology solutions not previously feasible for use in medical devices. In the past, nearly all patient data have traditionally been acquired by purpose-built machines manufactured by relatively small-scale
Read More
Avenda Health Receives FDA Exemption for AI-Enabled Prostate Cancer Therapy
What You Should Know:
- Avenda Health, an AI healthcare company creating the future of prostate cancer care, has received FDA Investigational Device Exemption (IDE) for its FocalPoint ablation system. The IDE will allow the technology, powered by iQuest, to be used in a randomized control trial to show superiority over the standard of care for the treatment of prostate cancer.
- FocalPoint is Avenda Health’s focal laser ablation system designed to treat localized prostate cancer
Read More
Ellipsis Health & Ceras Health Integrate to Bring Human Voice as a Biomarker for Mental Health
What You Should Know:
- Ellipsis Health and Ceras Health today announced a partnership that will integrate Ellipsis Health's breakthrough technology that uses the human voice as a biomarker for mental health and wellbeing into Ceras' clinical monitoring platform.
- This integration will combine Ellipsis Health's AI and deep learning technology with Ceras Health's clinical monitoring and health data analytics platform, enabling real-time severity scores for anxiety and depression to improve
Read More
FundamentalVR Raises $20M for VR Surgical Simulation Platform
What You Should Know:
- FundamentalVR has raised an additional $20M to significantly accelerate medical skill-transfer and increase surgical proficiency through its world-leading medical simulation platform, Fundamental Surgery.
- The funding was led by EQT Life Sciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. The new investments follow a Series A round in October 2019 and bring the
Read More
